CDC37 (V367) AntibodyProduct information
|100 µl (10 western blots)||-||Unavailable in your region|
Product Pathways - Protein Folding
CDC37 (V367) Antibody #3604
|3604S||100 µl (10 western blots)||---||In Stock||---|
|3604||carrier free and custom formulation / quantity||email request|
|W||1:1000||Human, Mouse, Rat, Monkey||Endogenous||50||Rabbit|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting
Specificity / Sensitivity
CDC37 (V367) Antibody detects endogenous levels of total CDC37 protein.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Val367 of human CDC37. Antibodies are purified by protein A and peptide affinity chromatography.
CDC37 is an important component of the HSP90 chaperone complex (1,2). It was initially identified for its involvement in cell-cycle progression and was later found to have a much broader role as a chaperone for a wide variety of kinases and other proteins (1-3). CDC37 protein has an amino-terminal kinase binding domain followed by a central HSP90 binding domain. It recruits and stabilizes kinases in the HSP90 complex by protecting the newly synthesized kinase peptide chain from degradation and promoting the next step of protein maturation (4,5). CDC37 also suppresses the ATPase activity of HSP90, thereby leading to conformational changes in the complex that preclude target kinase loading (6). CDC37 has been proposed as a therapeutic target because of its important role in multiple kinase pathways involved in proliferation and cancer cell survival, including Raf, Akt, Src, and ErbB2 pathways (7,8).
- Karnitz, L.M. and Felts, S.J. (2007) Sci STKE 2007, pe22.
- Caplan, A.J. et al. (2007) Trends Cell Biol 17, 87-92.
- Caplan, A.J. et al. (2007) Cell Cycle 6, 3145-7.
- Mandal, A.K. et al. (2007) J Cell Biol 176, 319-28.
- Lee, P. et al. (2002) J Cell Biol 159, 1051-9.
- Siligardi, G. et al. (2002) J Biol Chem 277, 20151-9.
- Kimura, Y. et al. (1997) Genes Dev 11, 1775-85.
- Gray, P.J. et al. (2008) Nat Rev Cancer 8, 491-5.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.